Page last updated: 2024-10-18

dimethylamine and Polycystic Ovary Syndrome

dimethylamine has been researched along with Polycystic Ovary Syndrome in 1 studies

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, L1
Hu, W1
Liu, Q1
Hao, Q1
Sun, B1
Zhang, Q1
Mao, S1
Qiao, J1
Yan, X1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Fujian Maternity and Child Health Hospital[NCT02992093]300 participants (Anticipated)Observational2016-12-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for dimethylamine and Polycystic Ovary Syndrome

ArticleYear
Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.
    Journal of proteome research, 2012, May-04, Volume: 11, Issue:5

    Topics: Adult; Amino Acids; Blood Glucose; Blood Proteins; Body Mass Index; Case-Control Studies; Citric Aci

2012